Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Gross Profit (2016 - 2025)

Veracyte (VCYT) has disclosed Gross Profit for 14 consecutive years, with $102.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 29.48% to $102.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $362.5 million through Dec 2025, up 21.6% year-over-year, with the annual reading at $362.5 million for FY2025, 21.6% up from the prior year.
  • Gross Profit hit $102.0 million in Q4 2025 for Veracyte, up from $91.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $102.0 million in Q4 2025 to a low of $20.4 million in Q1 2021.
  • Historically, Gross Profit has averaged $61.7 million across 5 years, with a median of $57.0 million in 2023.
  • Biggest five-year swings in Gross Profit: surged 254.32% in 2021 and later rose 10.97% in 2024.
  • Year by year, Gross Profit stood at $45.1 million in 2021, then rose by 24.48% to $56.2 million in 2022, then increased by 15.34% to $64.8 million in 2023, then grew by 21.56% to $78.8 million in 2024, then grew by 29.48% to $102.0 million in 2025.
  • Business Quant data shows Gross Profit for VCYT at $102.0 million in Q4 2025, $91.3 million in Q3 2025, and $89.8 million in Q2 2025.